Cipher Pharmaceuticals Inc. (CPHRF)
USD 9.66
(-0.41%)
USD 9.66
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 16.29 Million | 10.57 Million | 13.81 Million | 11.69 Million | 8.86 Million | 11.28 Million |
| Net Income | 20.75 Million | 26.63 Million | 7.75 Million | 4.38 Million | 2.63 Million | 1.2 Million |
| Depreciation & Amortization | 1.24 Million | 989 Thousand | 701 Thousand | 1.2 Million | 1.18 Million | 828 Thousand |
| Deferred income taxes | -2.78 Million | -14.31 Million | -114 Thousand | -1.41 Million | 1.28 Million | 1.26 Million |
| Stock-based compensation | 1.19 Million | 403 Thousand | 139 Thousand | 122 Thousand | -60 Thousand | 802 Thousand |
| Change in working capital | -3.33 Million | -3.03 Million | 4.67 Million | 1.72 Million | -618 Thousand | 4.89 Million |
| Other non-cash items | -780.62 Thousand | -109 Thousand | 652 Thousand | 5.66 Million | 4.43 Million | 2.29 Million |
| Investing Cash Flow | -146.64 Thousand | -81 Thousand | - | -760 Thousand | -1.46 Million | -24.48 Million |
| Investments in PPE | -146.64 Thousand | -81 Thousand | - | -760 Thousand | -1.31 Million | -6.62 Million |
| Acquisitions | - | - | - | - | -374 Thousand | -19.55 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -123 Thousand | - | - | -1052.83 | 221 Thousand | 1.7 Million |
| Financing Cash Flow | -5.34 Million | -1.91 Million | -2.47 Million | -8.13 Million | -10.52 Million | -1.4 Million |
| Debt repayment | -111 Thousand | -58 Thousand | -828 Thousand | -7.66 Million | -10 Million | -5.72 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.66 Million | -1.98 Million | -1.71 Million | -78 Thousand | - | - |
| Common Stock Issuance | 433.81 Thousand | 126.76 Thousand | 74.34 Thousand | 38 Thousand | 70 Thousand | 110 Thousand |
| Other Financing Activities | -113.03 Thousand | 132 Thousand | 75 Thousand | -426 Thousand | -597 Thousand | 4.2 Million |
| Accounts receivables | 1.74 Million | -144 Thousand | 2.56 Million | -342 Thousand | 1.59 Million | 11.43 Million |
| Accounts payables | 541.75 Thousand | -1.44 Million | -1.23 Million | 1.71 Million | -2 Million | -5.96 Million |
| Inventory | -845.22 Thousand | -502 Thousand | -758 Thousand | 151 Thousand | -271 Thousand | -276 Thousand |
| Other working capital | -4.77 Million | -940 Thousand | 4.1 Million | 197 Thousand | 69 Thousand | -6.26 Million |
| Cash at beginning of period | 28.82 Million | 20.54 Million | 9.14 Million | 6.34 Million | 10.35 Million | 28.24 Million |
| Cash at end of period | 39.62 Million | 28.83 Million | 20.54 Million | 9.14 Million | 6.34 Million | 10.35 Million |
| Capital Expenditure | -146.64 Thousand | -81 Thousand | - | -760 Thousand | -1.31 Million | -6.62 Million |
| Effect of forex changes on cash | 378 Thousand | -292 Thousand | 62 Thousand | -2000.00 | 49 Thousand | -87 Thousand |
| Net cash flow / Change in cash | 10.79 Million | 8.28 Million | 11.4 Million | 2.79 Million | -4.01 Million | -17.88 Million |
| Free Cash Flow | 16.14 Million | 10.49 Million | 13.81 Million | 10.93 Million | 7.54 Million | 4.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.99 Million | 4.9 Million | 20.75 Million | 7.86 Million | 7.03 Million | 3.07 Million |
| Depreciation & Amortization | 291.93 Thousand | 287.7 Thousand | 1.24 Million | 280.54 Thousand | 269 Thousand | 342 Thousand |
| Deferred income taxes | -490.77 Thousand | -1.94 Million | -2.78 Million | 1.33 Million | -4.02 Million | -16 Thousand |
| Stock-based compensation | 183 Thousand | 224 Thousand | 1.19 Million | 222 Thousand | 315 Thousand | 209 Thousand |
| Change in working capital | 2.79 Million | -1.68 Million | -3.33 Million | -6.38 Million | 1.94 Million | -214 Thousand |
| Other non-cash items | -1.47 Million | 3.06 Million | -780.62 Thousand | -827.08 Thousand | 436 Thousand | -446 Thousand |
| Investing Cash Flow | -10.96 Thousand | -5973.20 | -146.64 Thousand | -146.64 Thousand | - | - |
| Investments in PPE | -10.96 Thousand | -5973.20 | -146.64 Thousand | -146.64 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -123 Thousand | -123 Thousand | - | - |
| Financing Cash Flow | -5700.88 | -100.54 Thousand | -5.34 Million | -5.03 Million | -27 Thousand | -242 Thousand |
| Debt repayment | -29 Thousand | -28 Thousand | -111 Thousand | -36 Thousand | -29 Thousand | -21 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1284.79 | -175.21 Thousand | -5.66 Million | -5.19 Million | -132 Thousand | -254 Thousand |
| Common Stock Issuance | 24.57 Thousand | 102.53 Thousand | 433.81 Thousand | 200.07 Thousand | 132.79 Thousand | 33.32 Thousand |
| Other Financing Activities | 24 Thousand | 103 Thousand | -113.03 Thousand | -36.81 Thousand | 134 Thousand | 33 Thousand |
| Accounts receivables | 4.59 Million | -3.33 Million | 1.74 Million | 1.64 Million | -877 Thousand | -337 Thousand |
| Accounts payables | -1.8 Million | 1.49 Million | 541.75 Thousand | -2.51 Million | 2.6 Million | 377 Thousand |
| Inventory | -127.49 Thousand | 213.04 Thousand | -845.22 Thousand | -463.11 Thousand | 336 Thousand | -481 Thousand |
| Other working capital | 132.54 Thousand | -65.7 Thousand | -4.77 Million | -5.05 Million | -119 Thousand | 227 Thousand |
| Cash at beginning of period | 41.93 Million | 39.62 Million | 28.82 Million | 41.88 Million | 36.33 Million | 33.42 Million |
| Cash at end of period | 47.97 Million | 41.93 Million | 39.62 Million | 39.62 Million | 42.08 Million | 36.33 Million |
| Capital Expenditure | -10.96 Thousand | -5973.20 | -146.64 Thousand | -146.64 Thousand | - | - |
| Effect of forex changes on cash | -206 Thousand | -171 Thousand | 378 Thousand | 408 Thousand | -197 Thousand | 207 Thousand |
| Net cash flow / Change in cash | 6.03 Million | 2.31 Million | 10.79 Million | -2.26 Million | 5.74 Million | 2.91 Million |
| Free Cash Flow | 6.18 Million | 2.41 Million | 16.14 Million | 2.34 Million | 5.97 Million | 2.94 Million |
NAVA
POLYCHEM
SNFRF
DHAMPURSUG
270520
WKL